Navigation Links
Cystic Fibrosis Foundation Establishes Landmark Patient Assistance Foundation
Date:11/13/2008

Organization offsets rising drug costs with funding from pharmaceutical manufacturers

BETHESDA, Md., Nov. 13 /PRNewswire-USNewswire/ -- The Cystic Fibrosis Foundation today announced the launch of a Cystic Fibrosis Patient Assistance Foundation, a nonprofit subsidiary that will help patients pay for certain high-cost medications they cannot afford.

All funds to support patients will be provided exclusively by pharmaceutical manufacturers. No dollars donated to the CF Foundation will be used for patient assistance. CF Foundation donations will continue to support research for a cure.

"Treatment costs are escalating beyond many cystic fibrosis patients' ability to pay," said Robert J. Beall, Ph.D., President and CEO of the Foundation. "Thanks to remarkable advances in research and care, people with CF are living into their 40s, 50s and beyond. Our challenge now is to make sure people can afford the advanced treatments we are working so hard to develop."

The Cystic Fibrosis Patient Assistance Foundation is a first-of-its kind service dedicated solely for people with CF. It will help patients pay for essential, FDA-approved therapies for the treatment of lung disease. For information on the program, go to http://www.cfpaf.org or call 1-888-315-4154.

While 99 percent of people with cystic fibrosis have health insurance, increasingly patients are struggling to afford treatments because their coverage is not adequate. In fact, one in four CF patients report they skipped doses of medicine or purposefully took smaller doses in the past year because of the cost. Nearly one in five have delayed seeking care for the same reason.

The average annual cost for CF treatment is about $43,000.

In order to receive financial assistance, CF patients need to meet certain eligibility criteria. The criteria have been established by a separate board that oversees the Cystic Fibrosis Patient Assistance Foundation. Operation of the organization is contingent on continued funding from pharmaceutical manufacturers.

About the Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the leading organization in the United States devoted to curing and controlling cystic fibrosis. Headquartered in Bethesda, Md., the Foundation has more than 80 chapters and branch offices throughout the country and supports and accredits a nationwide network of 115 care center. For more information, visit http://www.cff.org.


'/>"/>
SOURCE Cystic Fibrosis Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Vitamin D Guidelines Too Low for Cystic Fibrosis Kids
2. Children with cystic fibrosis not well covered by guidelines for vitamin D needs
3. Mucous breakthrough in mice holds promise for cystic fibrosis
4. Five States Step Up Efforts to Screen Newborns for Cystic Fibrosis
5. Cystic Fibrosis Foundation Hosts Quality Improvement Summit - Caregivers from 15 States and Canada Gather in Hartford for Intensive Learning
6. GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend
7. Cystic Fibrosis Foundation President Rings Bell to Close New York Stock Exchange
8. Alabama Begins Mandatory Screening of Newborns for Cystic Fibrosis
9. Cystic Fibrosis Foundation Lauds Congress for Passage of Small Business Innovation Research Program
10. Study Points to New Treatments for Polycystic Kidney Disease
11. Lung transplants in cystic fibrosis patients with life-threatening bacteria sparks debate at ISHLT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... 22, 2017 , ... Sam & Associates Insurance Agency, a ... related services to residents of the region, is embarking on a charity effort ... wild lands. , Endangered Species International is committed to ending the anthropogenic trends ...
(Date:3/22/2017)... California (PRWEB) , ... March 22, 2017 , ... Old ... British boxing champ Ashley Theophane as a new Brand Ambassador. Theophane, who trained with ... light welterweight title in 2011. He has racked up an impressive number of wins ...
(Date:3/22/2017)... NJ (PRWEB) , ... March 22, 2017 , ... ... Group, the nation’s leading digital and print media enterprise focused on cancer patients, ... video content, has released a special 12-part educational video series, “No Ifs, Ands, ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... plan to cure Rett Syndrome, a devastating neurological disorder that afflicts 350,000 individuals ... located on the X chromosome, and almost exclusively strikes females. Following a ...
(Date:3/22/2017)... ... March 22, 2017 , ... University Orthopedics ... Orthopedic Surgery, Division of Hand, Upper Extremity and Microvascular Surgery at Newport Hospital. ... board-certified in both Orthopedics and Hand Surgery. , As the leader of ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... , 22. März 2017   ... und weltweit tätige Anbieter von Produkten und ... den Erwerb von EPL Archives Inc. bekannt, ... der Kunden im kompletten Zyklus regulierter Forschung, ... von Proben, Speicherung von Dokumenten und Zusatzdienstleistungen ...
(Date:3/22/2017)... , March 22, 2017  Ablation is ... for a wide range of purposes, from cancerous ... abnormally conducting cardiac tissue in atrial fibrillation and ... is pushing the researchers to innovate and improvise ... The ablation device global market is expected ...
(Date:3/22/2017)... 22, 2017 TapImmune, Inc. ... the development of innovative peptide and gene-based immunotherapeutics ... today announced that it will participate in two ... Glynn Wilson , Chairman and CEO of ... business, clinical pipeline and partnering opportunities for its ...
Breaking Medicine Technology: